TLR4 and hypertensive disorder: In SHR, a genetic model of hypertension with both neural and vascular alterations (Harwani et al., 2012; Leong et al., 2015), our group previously reported similar effects regarding lowering BP after long-term treatment with an anti-TLR4 antibody (Bomfim et al., 2012).